Engineering an aortic valve with cellular and mechanical functionality

Author(s)
Nachlas, Aline Louise Yonezawa
Editor(s)
Associated Organization(s)
Organizational Unit
Wallace H. Coulter Department of Biomedical Engineering
The joint Georgia Tech and Emory department was established in 1997
Organizational Unit
Supplementary to:
Abstract
Heart valve disease is an increasing clinical burden associated with high morbidity and mortality. Current, valve replacements have a number of risks, such as thrombogenicity and calcification. For pediatric patients, a significant issue is the lack of small implants capable of growing, resulting in several surgical interventions for valve refitting. Patient-specific, tissue engineered heart valves (TEHVs) have the potential to address these issues through their self-repairing and remodeling capacity. The overall objective of this thesis was to develop a TEHV that functions under physiological aortic valve conditions and has the potential to repair and remodel over time. The central hypothesis is a TEHV can be created by mimicking the structural components of the valve leaflet layers using 3D bioprinting and incorporating valvular interstitial cell (VIC)-like cells to actively regenerate and remodel. First, we generated a potential suitable cell source of human iPSC-derived mesenchymal stem cells (iMSCs) that mature into VIC-like cells. Next, we used 3D printing and a combination of poly-ε-caprolactone (PCL) and gelatin methacrylate - polyethylene (glycol) diacrylate (GelMA/PEGDA) hydrogel to create a cell-laden multilayered leaflet that recapitulates the layers of the valve leaflet. Lastly, the PCL-component of the valve leaflet was mounted onto a valve stent and feasibility studies were conducted using a left-ventricle flow simulator to evaluate the hemodynamic performance of the PCL-TEHV under aortic valve conditions. We demonstrated a cell source can be derived from autologous iPSCs, generated a multilayered leaflet scaffold using a combination of natural and synthetic biomaterials, and verified the feasibility of the leaflet under aortic flow conditions. These promising findings are the first steps to a pre-clinical TEHV with the ability to regenerate and remodel with the patient.
Sponsor
Date
2019-08-27
Extent
Resource Type
Text
Resource Subtype
Dissertation
Rights Statement
Rights URI